Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symvess for Extremity Arterial Injury in Adolescents
NCT07762313Phase 3Not yet recruiting
- Sponsor
- Humacyte
- Start
- Sep 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 3 trial of acellular tissue engineered vessel in arterial injury, sponsored by Humacyte. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
acellular tissue engineered vessel
03
Conditions
arterial injury
Beyond the preview
Go deeper on NCT07762313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762313.